Literature DB >> 18688693

Investigation of the immunoreactivities of NOS enzymes and the effect of sumatriptan in adolescent rats using an experimental model of migraine.

Semra Hiz Kurul1, Savas Demirpence, Müge Kiray, Kazim Tugyan, Osman Yilmaz, Galip Kose.   

Abstract

The aim was to investigate the immunoreactivities for NOS enzymes in frontal cortex and meningeal vessels after chemical stimulation of the subarachnoid space of adolescent rats and the effect of sumatriptan pre-treatment on the immunoreactivities of the NOS enzymes. Male adolescent Wistar rats were used. Rats in group 1 did not taken intracisternal injection. Rats in group 2 were taken intracisternal autologous blood injection, but no sumatriptan pre-treatment. Rats in group 3 were taken intracisternal autologous blood injection, but they were taken sumatriptan pre-treatment. Tissue samples were investigated for the presence of NOS immunoreactivity. The mean values of immunolabeling intensities for NOS enzymes in frontal cortex and meningeal vessels were significantly increased in group 2 compared to group 1. The mean values of immunolabeling intensities for NOS enzymes in frontal cortex and meningeal vessels were significantly reduced in group 3 compared to group 2. These results suggest that, chemical stimulation of the subarachnoid space increased the immunoreactivities of NOS enzymes in the brain of adolescent rats. The increased NOS immunoreactivities could be antagonized by pre-treatment with sumatriptan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688693      PMCID: PMC3452203          DOI: 10.1007/s10194-008-0056-4

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  34 in total

1.  Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat.

Authors:  P J Goadsby; A S Zagami
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

2.  Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics.

Authors:  Helle K Iversen; Jes Olesen; Peer Tfelt-Hansen
Journal:  Pain       Date:  1989-07       Impact factor: 6.961

3.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

4.  5-HT(1B/1D) serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway.

Authors:  C Suwattanasophon; P Phansuwan-Pujito; A Srikiatkhachorn
Journal:  Cephalalgia       Date:  2003-10       Impact factor: 6.292

5.  CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.

Authors:  K Nozaki; M A Moskowitz; P Boccalini
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

Authors:  H Kaube; K A Keay; K L Hoskin; R Bandler; P J Goadsby
Journal:  Brain Res       Date:  1993-11-26       Impact factor: 3.252

7.  Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space.

Authors:  K Nozaki; P Boccalini; M A Moskowitz
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

Review 8.  Nitric oxide is a key molecule in migraine and other vascular headaches.

Authors:  J Olesen; L L Thomsen; H Iversen
Journal:  Trends Pharmacol Sci       Date:  1994-05       Impact factor: 14.819

9.  Impairment of serotoninergic transmission is followed by adaptive changes in 5HT1B binding sites in the rat suprachiasmatic nucleus.

Authors:  C Manrique; A M François-Bellan; L Segu; D Becquet; M Héry; M Faudon; F Héry
Journal:  Brain Res       Date:  1994-11-07       Impact factor: 3.252

Review 10.  Neurobiology of migraine.

Authors:  Daniela Pietrobon; Jörg Striessnig
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

View more
  1 in total

1.  Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.

Authors:  Manel Ben Aissa; Alycia F Tipton; Zachariah Bertels; Ronak Gandhi; Laura S Moye; Madeline Novack; Brian M Bennett; Yueting Wang; Vladislav Litosh; Sue H Lee; Irina N Gaisina; Gregory Rj Thatcher; Amynah A Pradhan
Journal:  Cephalalgia       Date:  2017-10-12       Impact factor: 6.292

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.